Serveur d'exploration sur la musique en Sarre

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Danger signals and skin sensitization

Identifieur interne : 000C62 ( Main/Exploration ); précédent : 000C61; suivant : 000C63

Danger signals and skin sensitization

Auteurs : I. Kimber [Royaume-Uni] ; M. Cumberbatch [Royaume-Uni] ; R. J. Dearman [Royaume-Uni] ; C. E. M. Griffiths [Royaume-Uni]

Source :

RBID : ISTEX:8D83CB0E5B4E7E46ABB16B639A65C513623A8340

English descriptors


Url:
DOI: 10.1046/j.1365-2133.2002.48776.x


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Danger signals and skin sensitization</title>
<author>
<name sortKey="Kimber, I" sort="Kimber, I" uniqKey="Kimber I" first="I." last="Kimber">I. Kimber</name>
</author>
<author>
<name sortKey="Cumberbatch, M" sort="Cumberbatch, M" uniqKey="Cumberbatch M" first="M." last="Cumberbatch">M. Cumberbatch</name>
</author>
<author>
<name sortKey="Dearman, R J" sort="Dearman, R J" uniqKey="Dearman R" first="R. J." last="Dearman">R. J. Dearman</name>
</author>
<author>
<name sortKey="Griffiths, C E M" sort="Griffiths, C E M" uniqKey="Griffiths C" first="C. E. M." last="Griffiths">C. E. M. Griffiths</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:8D83CB0E5B4E7E46ABB16B639A65C513623A8340</idno>
<date when="2002" year="2002">2002</date>
<idno type="doi">10.1046/j.1365-2133.2002.48776.x</idno>
<idno type="url">https://api.istex.fr/document/8D83CB0E5B4E7E46ABB16B639A65C513623A8340/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000E56</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000E56</idno>
<idno type="wicri:Area/Istex/Curation">000D84</idno>
<idno type="wicri:Area/Istex/Checkpoint">000A54</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000A54</idno>
<idno type="wicri:doubleKey">0007-0963:2002:Kimber I:danger:signals:and</idno>
<idno type="wicri:Area/Main/Merge">000C63</idno>
<idno type="wicri:Area/Main/Curation">000C62</idno>
<idno type="wicri:Area/Main/Exploration">000C62</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Danger signals and skin sensitization</title>
<author>
<name sortKey="Kimber, I" sort="Kimber, I" uniqKey="Kimber I" first="I." last="Kimber">I. Kimber</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ</wicri:regionArea>
<wicri:noRegion>Cheshire SK10 4TJ</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Cumberbatch, M" sort="Cumberbatch, M" uniqKey="Cumberbatch M" first="M." last="Cumberbatch">M. Cumberbatch</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ</wicri:regionArea>
<wicri:noRegion>Cheshire SK10 4TJ</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Dearman, R J" sort="Dearman, R J" uniqKey="Dearman R" first="R. J." last="Dearman">R. J. Dearman</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ</wicri:regionArea>
<wicri:noRegion>Cheshire SK10 4TJ</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Griffiths, C E M" sort="Griffiths, C E M" uniqKey="Griffiths C" first="C. E. M." last="Griffiths">C. E. M. Griffiths</name>
<affiliation wicri:level="4">
<orgName type="university">Université de Manchester</orgName>
<country>Royaume-Uni</country>
<placeName>
<settlement type="city">Manchester</settlement>
<region type="nation">Angleterre</region>
<region nuts="2" type="region">Grand Manchester</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">British Journal of Dermatology</title>
<idno type="ISSN">0007-0963</idno>
<idno type="eISSN">1365-2133</idno>
<imprint>
<publisher>Blackwell Science Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2002-09">2002-09</date>
<biblScope unit="volume">147</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="613">613</biblScope>
<biblScope unit="page" to="613">613</biblScope>
</imprint>
<idno type="ISSN">0007-0963</idno>
</series>
<idno type="istex">8D83CB0E5B4E7E46ABB16B639A65C513623A8340</idno>
<idno type="DOI">10.1046/j.1365-2133.2002.48776.x</idno>
<idno type="ArticleID">BJD4877_6</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0007-0963</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Acad dermatol</term>
<term>Adaptive immunity</term>
<term>Allergen</term>
<term>Allergic contact dermatitis</term>
<term>Angiotensin</term>
<term>Apoptosis</term>
<term>Apoptotic cells</term>
<term>Arch dermatol</term>
<term>Asthmatic patients</term>
<term>Atrophoderma</term>
<term>Autosomal recessive inheritance</term>
<term>Basal</term>
<term>Basal cell carcinoma</term>
<term>Basal cell carcinomas</term>
<term>Basiliximab</term>
<term>Biopsy</term>
<term>Blood transfusion</term>
<term>Bone marrow</term>
<term>Bone pain</term>
<term>Book deals</term>
<term>Book reviews</term>
<term>Bowel</term>
<term>Bowel disease</term>
<term>British association</term>
<term>British journal</term>
<term>British skin foundation</term>
<term>Bystander</term>
<term>Candesartan cilexetil</term>
<term>Carcinoma</term>
<term>Cardiac abnormalities</term>
<term>Case report</term>
<term>Cell death</term>
<term>Cell markers</term>
<term>Cell precursor</term>
<term>Central role</term>
<term>Chain gene</term>
<term>Chemical allergen</term>
<term>Chemical allergens</term>
<term>Chronic trauma</term>
<term>Clin</term>
<term>Clinical features</term>
<term>Clinical investigation</term>
<term>Clinicopathologic study</term>
<term>Commonest skin cancer</term>
<term>Congenital</term>
<term>Congenital ichthyosis</term>
<term>Contact dermatitis</term>
<term>Correspondence figure</term>
<term>Creatinine clearance</term>
<term>Crmo</term>
<term>Cutaneous</term>
<term>Cutaneous lesions</term>
<term>Cyclosporin</term>
<term>Cytokine</term>
<term>Cytokine signals</term>
<term>Cytotoxic molecules</term>
<term>Danger hypothesis</term>
<term>Danger model</term>
<term>Danger signals</term>
<term>Dermatitis</term>
<term>Dermatol</term>
<term>Dermatol surg oncol</term>
<term>Dermatologist</term>
<term>Dermatology</term>
<term>Differential diagnosis</term>
<term>Docetaxel</term>
<term>Dramatic response</term>
<term>Drug compatibility</term>
<term>Drug intake</term>
<term>Drug reaction</term>
<term>Drug reactions</term>
<term>Eosin staining</term>
<term>Epidermal</term>
<term>Erosive</term>
<term>Erosive vulvovaginal lichen planus</term>
<term>Extensor surfaces</term>
<term>Family history</term>
<term>Fatal hyalohyphomycosis</term>
<term>Flow cytometric analysis</term>
<term>Focal hypogranulosis</term>
<term>Follicular</term>
<term>Follicular atrophoderma</term>
<term>Foreign antigen</term>
<term>Full blood cell count</term>
<term>Functional subpopulations</term>
<term>Fungal melanonychia</term>
<term>Fusarium</term>
<term>Fusarium onychomycosis</term>
<term>Fusarium oxysporum</term>
<term>Fusarium solani</term>
<term>Genodermatosis</term>
<term>Gold particles</term>
<term>Granulocytic</term>
<term>Granulocytic sarcoma</term>
<term>Granulocytic sarcomas</term>
<term>Great toenails</term>
<term>Haematopoietic neoplasms</term>
<term>Happle syndrome</term>
<term>Host resistance</term>
<term>Hypotrichosis</term>
<term>Ichthyosis</term>
<term>Ichthyosis vulgaris</term>
<term>Ichthyotic skin</term>
<term>Imiquimod</term>
<term>Immune</term>
<term>Immune response</term>
<term>Immune system</term>
<term>Immunohistochemical staining</term>
<term>Immunol</term>
<term>Important role</term>
<term>Inheritance pattern</term>
<term>Initial presentation</term>
<term>Intralesional corticosteroids</term>
<term>Introductory section</term>
<term>Irregular diameter</term>
<term>Keratinocytes</term>
<term>Lactophenol cotton</term>
<term>Langerhans</term>
<term>Langerhans cell migration</term>
<term>Langerhans cells</term>
<term>Large part</term>
<term>Lesion</term>
<term>Leukaemia</term>
<term>Leukaemia cutis</term>
<term>Lichen</term>
<term>Local wound therapy</term>
<term>Localized</term>
<term>Lower extremities</term>
<term>Lower right</term>
<term>Lymph</term>
<term>Lymph nodes</term>
<term>Lymphoma</term>
<term>Major improvement</term>
<term>Malignant</term>
<term>Malignant melanoma</term>
<term>Mechanical injury</term>
<term>Melanoma</term>
<term>Metastasis</term>
<term>Metastatic</term>
<term>Metastatic skin area</term>
<term>Monoclonal antibody</term>
<term>Montelukast</term>
<term>Montelukast therapy</term>
<term>Mouse skin</term>
<term>Multifocal</term>
<term>Multifocal osteomyelitis</term>
<term>Myeloid</term>
<term>Myeloid cell markers</term>
<term>Myeloid precursor</term>
<term>Nail</term>
<term>Nail unit</term>
<term>Nailfold capillaroscopy</term>
<term>Natural killer</term>
<term>Ndings</term>
<term>Neural cell adhesion molecule</term>
<term>Nimesulide</term>
<term>Node</term>
<term>Normal range</term>
<term>Nuclear accumulation</term>
<term>Onychomycosis</term>
<term>Oral prednisolone</term>
<term>Oral prednisone</term>
<term>Oral sulphasalazine</term>
<term>Oral terbinafine</term>
<term>Osteomyelitis</term>
<term>Other cytokines</term>
<term>Other signals</term>
<term>Paclitaxel</term>
<term>Palmoplantar</term>
<term>Palmoplantar keratoderma</term>
<term>Palmoplantar pustular psoriasis</term>
<term>Patch testing</term>
<term>Pediatr dermatol</term>
<term>Pigmentation disorders</term>
<term>Planus</term>
<term>Platelet</term>
<term>Platelet count</term>
<term>Positive staining</term>
<term>Positive tunel staining</term>
<term>Precursor</term>
<term>Professional radiodermatitis</term>
<term>Psoriasis</term>
<term>Pustular</term>
<term>Pustular psoriasis</term>
<term>Pustule</term>
<term>Pustuloderma</term>
<term>Pyoderma gangrenosum</term>
<term>Rare case</term>
<term>Receptor</term>
<term>References figure</term>
<term>Regional lymph nodes</term>
<term>Santa cruz biotechnology</term>
<term>Sarcoma</term>
<term>Sartan</term>
<term>Sartan treatment</term>
<term>Sartans</term>
<term>Scalp hair</term>
<term>Second report</term>
<term>Sensitization</term>
<term>Severe thrombocytopenia</term>
<term>Skin biopsies</term>
<term>Skin biopsy</term>
<term>Skin disorders</term>
<term>Skin involvement</term>
<term>Skin irritation</term>
<term>Skin lesions</term>
<term>Skin metastases</term>
<term>Skin sensitization</term>
<term>Solani</term>
<term>Successful treatment</term>
<term>Syndrome</term>
<term>Systemic vasculitis</term>
<term>Tacrolimus</term>
<term>Taipei</term>
<term>Teledermatology</term>
<term>Teledermatology service</term>
<term>Terminal deoxynucleotidyl deoxyuridine triphosphate nick</term>
<term>Therapeutic class</term>
<term>Thrombocytopenia</term>
<term>Time course</term>
<term>Tissue remodelling</term>
<term>Tissue staining</term>
<term>Toenail</term>
<term>Topical</term>
<term>Topical application</term>
<term>Topical cyclosporin</term>
<term>Topical imiquimod</term>
<term>Topical imiquimod treatment</term>
<term>Topical tacrolimus</term>
<term>Topical treatment</term>
<term>Toxic pustuloderma</term>
<term>Transient myalgia</term>
<term>Trauma</term>
<term>Tumour</term>
<term>Tumour cells</term>
<term>Tumour necrosis</term>
<term>Tunel</term>
<term>Tunel staining</term>
<term>Ultrasound imaging</term>
<term>University hospital</term>
<term>Upper right</term>
<term>Viral infection</term>
<term>Vulval</term>
<term>Vulval mucosa</term>
<term>Western blot analysis</term>
<term>Wire brush</term>
<term>Woolly</term>
<term>Woolly hair</term>
<term>Wooly hair</term>
<term>Wound edge</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations>
<list>
<country>
<li>Royaume-Uni</li>
</country>
<region>
<li>Angleterre</li>
<li>Grand Manchester</li>
</region>
<settlement>
<li>Manchester</li>
</settlement>
<orgName>
<li>Université de Manchester</li>
</orgName>
</list>
<tree>
<country name="Royaume-Uni">
<noRegion>
<name sortKey="Kimber, I" sort="Kimber, I" uniqKey="Kimber I" first="I." last="Kimber">I. Kimber</name>
</noRegion>
<name sortKey="Cumberbatch, M" sort="Cumberbatch, M" uniqKey="Cumberbatch M" first="M." last="Cumberbatch">M. Cumberbatch</name>
<name sortKey="Dearman, R J" sort="Dearman, R J" uniqKey="Dearman R" first="R. J." last="Dearman">R. J. Dearman</name>
<name sortKey="Griffiths, C E M" sort="Griffiths, C E M" uniqKey="Griffiths C" first="C. E. M." last="Griffiths">C. E. M. Griffiths</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sarre/explor/MusicSarreV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C62 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000C62 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sarre
   |area=    MusicSarreV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:8D83CB0E5B4E7E46ABB16B639A65C513623A8340
   |texte=   Danger signals and skin sensitization
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sun Jul 15 18:16:09 2018. Site generation: Tue Mar 5 19:21:25 2024